Records containing: Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-03-26Unrelated Donor Hematopoietic Stem Cell Transplantation After Nonmyeloablative Conditioning For Patients With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2013-03-26A PROSPECTIVE RANDOMIZED, DOUBLE-BLIND, COMPARATIVE, MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF NYSTATIN AND AMPHOTERICIN B FOR EMPIRIC ANTIFUNGAL TREATMENT IN NEUTROPENIC PATIENTS
-
CLINICAL_TRIALS study record update · 2013-03-26NON-T-CELL DEPLETED HLA-HAPLOIDENTICAL FAMILIAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION AFTER REDUCED INTENSITY CONDITIONING
-
CLINICAL_TRIALS study record update · 2013-03-12ClinicalTrials.gov study NCT01809392
-
CLINICAL_TRIALS study record update · 2013-03-07A Phase II Trial of IV Busulfan (Busulfex) and Melphalan as a Preparatory Regimen Prior to Allogeneic Bone Marrow Transplantation for the Treatment of Advanced and High Risk Hematologic Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-02-26A Proof of Concept Study of Non-DNA Damaging DNMT1 Depletion Therapy for Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2013-02-20Donor NK Cell Infusion for Progression/Recurrence of Underlying Malignant Disorders After HLA-haploidentical HCT - a Phase 1-2 Study
-
CLINICAL_TRIALS study record update · 2013-02-15Multi-Center, Prospective, Randomized, Double-Blinded, Controlled Clinical Trial to Evaluate the Safety and Effectiveness of an Antimicrobial Catheter Lock Solution in Maintaining Catheter Patency and Preventing Catheter Related Blood Stream Infections (CRBSI)
-
CLINICAL_TRIALS study record update · 2013-02-15A Phase I Study of the Biologic and Clinical Effects of 5-AZA-2'Deoxycytidine (DAC) in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2013-02-11A Dose Finding Study of R115777 (NSC 702818) in Patients With Advanced Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase I Study of 5-AZA-2'-Deoxycytidine and Depsipeptide in Patients With Relapsed/Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disease
-
CLINICAL_TRIALS study record update · 2013-02-08Phase I Study of MGI-114 (NSC#683863) in Patients With Refractory Myelodysplastic Syndromes, Acute Leukemia and Chronic Myelogenous Leukemia in Blastic Phase (CML-BP)
-
CLINICAL_TRIALS study record update · 2013-02-06Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy
-
CLINICAL_TRIALS study record update · 2013-02-04A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
-
CLINICAL_TRIALS study record update · 2013-02-01Phase I Trial of Interleukin-12 Followed by Interferon-Alpha
-
CLINICAL_TRIALS study record update · 2013-01-31A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial Assessing The Safety And Efficacy Of Thalidomide (THALOMID) For The Treatment Of Anemia In Red Blood Cell Transfusion-Dependent Patients With Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2013-01-31Phase I/II Study of Combined Treatment With Amifostine (Ethyol) and Topotecan (Hycamtin MS) in Patients With Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2013-01-18Does Hypericum Reduce Fatigue in Cancer Patients on Chemotherapy? A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2013-01-18A Phase I Study of Salicylate for Adult Patients With Advanced Myelodysplastic Disorders or Acute Myelogenous Leukemia
-
CLINICAL_TRIALS study record update · 2013-01-16Vaccination of Patients With Myelodysplastic Syndrome Against Mutated RAS Proteins: A Pilot Trial
-
CLINICAL_TRIALS study record update · 2013-01-09A Pilot Study of IV Clofarabine for Patients With Myelodysplastic Syndrome Who Have Failed 5-azacytidine
-
CLINICAL_TRIALS study record update · 2013-01-07Phase II Trial Of Non-Myeloablative Regimen Combining Melphalan, Fludarabine, And Anti-CD52 Monoclonal Antibody (CAMPATH-1H) Followed By An Unmodified Hematopoietic Cell Transplant From An HLA Compatible Related Or Unrelated Donor For Treatment Of Lymphohematopoietic Malignancies
-
CLINICAL_TRIALS study record update · 2012-12-21A Phase II Trial of 5-Azacytidine (NSC #102816) and Ethyol (Amifostine) in the Treatment of Adults With Myelodysplastic Syndromes
-
CLINICAL_TRIALS study record update · 2012-12-17Allogeneic Sibling and Unrelated Donor Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Busulfan, Etoposide and Cyclophosphamide
-
CLINICAL_TRIALS study record update · 2012-12-11Allogeneic Bone Marrow Transplantation for Marrow Failure States